Jazz Pharmaceuticals' Acquisition of GW Pharmaceuticals Closes

Jazz Pharmaceuticals (NASDAQ:JAZZ) and GW Pharmaceuticals are now under the same corporate roof. The two companies announced Wednesday that Jazz's acquisition of GW has been completed. This brings the $7.6 billion cash-and-stock deal, first announced in early February, to a close.